Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

COVID-19

Free Subscription Articles published in J Travel Med Retrieve available abstracts of 99 articles: HTML format

Single Articles

July 2026
1. KASSIANOS G, Goodyer L, Gomensoro EEB, Doobaree U, et al
   Assessment of the healthcare burden of dengue disease in England: a retrospective analysis (2010-2023).
   J Travel Med. 2026 Jul 2:taag059. doi: 10.1093.
   PubMed     Abstract available
   
   
   June 2026
2. LUBBERT C, Fruhwein M, Dinjer CS, Machler C, et al
   Assessment of the healthcare burden of dengue disease in Germany: a retrospective analysis of statutory health insurance data (2014-2023).
   J Travel Med. 2026 Jun 11:taag047. doi: 10.1093.
   PubMed     Abstract available
   
   
   January 2026
3. AL-ANSARI F, Al Ansari M, Rashid H, Al-Ansari B, et al
   Facemask use at the Arbaeen Mass Gathering during and after COVID-19 pandemic: a naked eye survey.
   J Travel Med. 2026 Jan 30:taag010. doi: 10.1093.
   PubMed     Abstract available
   
   
   October 2025
4. GIBB RD, Brum JM, Sloan KJ, Pitz AM, et al
   Revisiting the efficacy of bismuth subsalicylate for the prevention of traveller's diarrhoea.
   J Travel Med. 2025;32:taaf076.
   PubMed     Abstract available
   
   
   August 2025
5. PERLANT C, Klitting R, Colizza V, Gaythorpe KAM, et al
   A framework to assess the risk of Yellow Fever emergence.
   J Travel Med. 2025 Aug 6:taaf081. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2025
6. PATEL P, Freedman DO
   Considerations for prevention and standby emergency treatment for travellers at high- risk of COVID-19 hospitalization.
   J Travel Med. 2025 Apr 4:taaf029. doi: 10.1093.
   PubMed    
   
   
   March 2025
7. SHIFERAW W, Dean JA, Mills D, Lau CL, et al
   Overseas- and locally-acquired sexually transmissible infections in Australia, 2017-2023.
   J Travel Med. 2025 Mar 5:taaf022. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2024
8. KANAUJIYA AK, Tiwari V
   Health implications of mass gatherings: Kumbh Mela in India 2025.
   J Travel Med. 2024;31:taae076.
   PubMed    
   
   
   
9. POPESCU C, Abu-Siam I, Khalifa A, Ababneh H, et al
   Lessons learned from Jordan's response to the Syria refugee crisis.
   J Travel Med. 2024;31:taae063.
   PubMed    
   
   
   July 2024
10. RAJPUT V, Das R, Pramanik R, Nannaware K, et al
    Early Detection of KP.2 SARS-CoV-2 Variant using Wastewater-based Genomic Surveillance in Pune, Maharashtra, India.
    J Travel Med. 2024 Jul 17:taae097. doi: 10.1093.
    PubMed    
    
    
    June 2024
11. WEE LE, Lim JT, Tan JYJ, Malek MIBA, et al
    Dengue versus COVID-19: Comparing the incidence of cardiovascular, neuropsychiatric, and autoimmune complications.
    J Travel Med. 2024 Jun 12:taae081. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. KOMAKECH A, Baki KA, Izudi J
    Visa Relaxation Policies and Potential Implications on Public Health in Africa.
    J Travel Med. 2024;31:taae032.
    PubMed    
    
    
    May 2024
13. TAY M, Lee B, Ismail MH, Yam J, et al
    Usefulness of aircraft and airport wastewater for monitoring multiple pathogens including SARS-CoV-2 variants.
    J Travel Med. 2024 May 30:taae074. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2024
14. CHEMAITELLY H, Coyle P, Kacem MAB, Ayoub HH, et al
    Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant.
    J Travel Med. 2024 Apr 9:taae053. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2024
15. WARDLE J, Bhatia S, Cori A, Nouvellet P, et al
    Temporal variations in international air travel: implications for modelling the spread of infectious diseases.
    J Travel Med. 2024 Mar 17:taae062. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. QUIGLEY AL, Kunasekaran M, Stone H, Honeyman D, et al
    The impact of the cruise ship coral princess on COVID-19 transmission in regional Western Australia in 2022.
    J Travel Med. 2024 Mar 12:taae044. doi: 10.1093.
    PubMed    
    
    
    
17. WANNIGAMA DL, Amarasiri M, Phattharapornjaroen P, Hurst C, et al
    Wastewater-based epidemiological surveillance of SARS-CoV-2 new variants BA.2.86 and offspring JN.1 in south and Southeast Asia.
    J Travel Med. 2024 Mar 4:taae040. doi: 10.1093.
    PubMed    
    
    
    February 2024
18. MARTINEZ-LACALZADA M, Cruz A, Subira C, Vera I, et al
    Lack of a non-specific protective effect of prior yellow fever vaccination against COVID-19.
    J Travel Med. 2024 Feb 15:taae027. doi: 10.1093.
    PubMed    
    
    
    January 2024
19. CHIU NC, Chi H, Weng SL, Lin CY, et al
    Unprecedented dengue outbreak in Taiwan following COVID-19.
    J Travel Med. 2024 Jan 21:taae015. doi: 10.1093.
    PubMed    
    
    
    
20. SOHAIL A, Anders KL, McGuinness SL, Leder K, et al
    The epidemiology of imported and locally-acquired dengue in Australia, 2012-2022.
    J Travel Med. 2024 Jan 18:taae014. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. MOORE JE, Millar BC
    Improving health literacy of passengers of cruise ships: readability of passenger-facing COVID-19 information provided by commercial cruise lines-an infodemiology study.
    J Travel Med. 2024 Jan 11:taae006. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. JAMES ER, Church LWP, Hoffman SL, Robertson BD, et al
    Piloting delivery of PfSPZ vaccines for malaria through a cryogenic vaccine cold chain to travel and military medicine clinics.
    J Travel Med. 2024 Jan 11:taae007. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2023
23. ALLEL K, Cabada MM, Lau C, Mills D, et al
    Causes of death among international travellers in Peru, 2017 to 2021.
    J Travel Med. 2023 Dec 21:taad163. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. ANAGNOSTOPOULOS A, Fehr J
    Rebound and steep increase of international travel after the COVID-19 pandemic: where are we going from here?
    J Travel Med. 2023 Dec 14:taad158. doi: 10.1093.
    PubMed    
    
    
    November 2023
25. BOYD S, Matsee W, Pisutsan P, Kamolrattanakul S, et al
    Incidence and Influencing Factors of Psychological Problems among International Travelers During Quarantine.
    J Travel Med. 2023 Nov 25:taad151. doi: 10.1093.
    PubMed    
    
    
    
26. RAZAI MS, Mansour R, Goldsmith L, Freeman S, et al
    Interventions to increase vaccination against COVID-19, influenza and pertussis during pregnancy: a systematic review and meta-analysis.
    J Travel Med. 2023 Nov 2:taad138. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2023
27. NORMAN FF, Diaz J, Martin-Davila P, Tato M, et al
    Bilateral pulmonary infiltrates in a traveler from Saudi Arabia with probable electronic or vaping associated lung injury (EVALI).
    J Travel Med. 2023 Oct 19:taad133. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2023
28. QIU H, Zhao S, Cheung AW, Yeoh EK, et al
    Association of Vaccine Pass policy and Omicron incidence with COVID vaccine uptakes in Hong Kong.
    J Travel Med. 2023;30:taad061.
    PubMed    
    
    
    August 2023
29. GROSSMAN T, Vainer J, Paran Y, Studensky L, et al
    Emergence of artemisinin-based combination treatment failure in patients returning from sub-Saharan Africa with P. falciparum malaria.
    J Travel Med. 2023 Aug 22:taad114. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. ZHANG Y, Liu Y, Gao Y, Man S, et al
    An alarming rise in COVID-19-related acute macular Neuroretinopathy in China: a cross-sectional multimodal imaging study.
    J Travel Med. 2023 Aug 10:taad109. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. CHEMAITELLY H, Ayoub HH, AlMukdad S, Faust JS, et al
    Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections.
    J Travel Med. 2023 Aug 9:taad106. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
32. POTIN M, Carron PN, Genton B
    Injuries and medical emergencies among international travelers.
    J Travel Med. 2023 Jul 5:taad088. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
33. YAMAKAWA M, Tanaka Y, Tokinobu A, Tsuda T, et al
    Preparedness for measles among Japanese travelers to India after the COVID-19 pandemic.
    J Travel Med. 2023 Jun 27:taad086. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. STEFFEN R, Chen LH, Leggat PA
    Travel vaccines-priorities determined by incidence and impact.
    J Travel Med. 2023 Jun 21:taad085. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. DEAL A, Crawshaw AF, Carter J, Knights F, et al
    Defining drivers of under-immunisation and vaccine hesitancy in refugee and migrant populations to support strategies to strengthen uptake of COVID-19 vaccines: a rapid review.
    J Travel Med. 2023 Jun 19:taad084. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. WAN EYF, Zhang R, Mathur S, Yan VKC, et al
    Post-acute sequelae of COVID-19 in older persons: multi-organ complications and mortality.
    J Travel Med. 2023 Jun 13:taad082. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2023
37. BUTT AA, Coyle PV, Abu-Raddad LJ, Tang P, et al
    Middle East respiratory syndrome coronavirus (MERS-CoV) and the 2022 world cup football tournament in Qatar.
    J Travel Med. 2023 May 25:taad052. doi: 10.1093.
    PubMed    
    
    
    
38. ZHANG Q, Ye Y, Zeng DD
    Travel restrictions cannot prevent the introduction of new COVID variants.
    J Travel Med. 2023 May 17:taad066. doi: 10.1093.
    PubMed    
    
    
    
39. KITAYA S, Baba H, Okamoto M, Sakamoto M, et al
    Severe pneumonia due to legionella and SARS-CoV-2 co-infection necessitating medical evacuation from a cargo ship.
    J Travel Med. 2023 May 9:taad067. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. PILIPENCO A, Forinova M, Maskova H, Honig V, et al
    Negligible risk of surface transmission of SARS-CoV-2 in public transportation.
    J Travel Med. 2023 May 3:taad065. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2023
41. BAI Y, Shao Z, Zhang X, Chen R, et al
    Reproduction number of SARS-CoV-2 omicron variants, China, December 2022-January 2023.
    J Travel Med. 2023 Apr 12:taad049. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. HAN C, Seo H, Cho S, Chiara A, et al
    Impact of travel restrictions for travellers from China on the internal spread of SARS-CoV-2 in South Korea.
    J Travel Med. 2023 Apr 11:taad047. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. LIBMAN MD
    Correspondence letter regarding 'is standby therapy for Covid-19 a practical option for travellers?'.
    J Travel Med. 2023 Apr 3:taad042. doi: 10.1093.
    PubMed    
    
    
    March 2023
44. NORMAN FF, Chen LH
    Travel-associated Melioidosis: a narrative review.
    J Travel Med. 2023 Mar 27:taad039. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. MURAKAMI M, Kitajima M, Endo N, Ahmed W, et al
    The growing need to establish a global wastewater surveillance consortium for future pandemic preparedness.
    J Travel Med. 2023 Mar 16:taad035. doi: 10.1093.
    PubMed    
    
    
    
46. DIOUF C, Ouaddane I, Goumballa N, Sambou M, et al
    Circulation of SARS-CoV-2 virus among pilgrims at the 2022 grand Magal of Touba.
    J Travel Med. 2023 Mar 7:taad024. doi: 10.1093.
    PubMed    
    
    
    
47. VINETTI G, Micarelli A, Falla M, Randi A, et al
    Surgical masks and filtering facepiece class 2 respirators (FFP2) have no major physiological effects at rest and during moderate exercise at 3000 m altitude. A randomised controlled trial.
    J Travel Med. 2023 Mar 6:taad031. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2023
48. FLATEAU C, Picque M, Cornaglia C, Pitsch A, et al
    Factors associated with delay in seeking healthcare for imported malaria: a retrospective study in a French hospital.
    J Travel Med. 2023 Feb 22:taad023. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. YUSOF NBM, Khor ZS, Bakar RSBA, Zaman KHBK, et al
    Linkage disequilibrium suggests genomic stability in omicron clades of SARS-CoV-2 from the ASEAN countries.
    J Travel Med. 2023 Feb 16:taad020. doi: 10.1093.
    PubMed    
    
    
    January 2023
50. GOEL K, Sen A, Satapathy P, Kumar P, et al
    Human rabies control in the era of post-COVID-19: a call for action.
    J Travel Med. 2023 Jan 28:taad009. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2022
51. GUAGLIARDO SAJ, Quilter LAS, Uehara A, White SB, et al
    COVID-19 on the Nile: a cross-sectional investigation of COVID-19 among Nile River cruise travellers returning to the United States, February-march 2020.
    J Travel Med. 2022 Dec 29:taac153. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. THAICHAROEN S, Meunrat S, Leng-Ee W, Koyadun S, et al
    How Thailand's tourism industry coped with COVID-19 pandemics: a lesson from the pilot Phuket tourism sandbox project.
    J Travel Med. 2022 Dec 23:taac151. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2022
53. WILLIAMSON KM, Butler M, Elton B, Taylor J, et al
    Transmission of SARS-CoV-2 Delta variant from an infected aircrew member on a short-haul domestic flight, Australia 2021.
    J Travel Med. 2022 Nov 30:taac144. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. KASSEM II, Osman M, Jaafar H, El Omari K, et al
    Refugee settlements, COVID-19, pollution, and the unfolding cholera outbreak in Lebanon.
    J Travel Med. 2022 Nov 26:taac142. doi: 10.1093.
    PubMed    
    
    
    
55. TEGALLY H, Khan K, Huber C, Oliveira T, et al
    Shifts in global mobility dictate the synchrony of SARS-CoV-2 epidemic waves.
    J Travel Med. 2022 Nov 11. pii: 6823497. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. DI STEFANO LL, Libera BD, Rodi P
    Effectiveness and Use of Avalanche Airbags in Mortality Reduction among Winter-Recreationists.
    J Travel Med. 2022 Nov 9. pii: 6812861. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. ABOU-SALEH H, Abo-Halawa BY, Younes S, Younes N, et al
    Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection.
    J Travel Med. 2022 Nov 7. pii: 6808421. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2022
58. FREEDMAN DO
    Air Travel and SARS-CoV-2: Many Remaining Knowledge Gaps.
    J Travel Med. 2022 Oct 27. pii: 6775351. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. WAN EYF, Mok AHY, Yan VKC, Ying Chan CI, et al
    Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case-control study.
    J Travel Med. 2022 Oct 17. pii: 6761907. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. GARCIA-BEREGUIAIN MA, Perez F, Parra-Vera H, Bruno A, et al
    High SARS-CoV-2 viral load in travellers arriving in Spain with a negative COVID-19 test prior to departure: Ecuador as a model for COVID-19 testing quality in Latin America.
    J Travel Med. 2022 Oct 17. pii: 6761911. doi: 10.1093.
    PubMed    
    
    
    
61. CHOY B, Bristowe H, Khozoee B, Lampejo T, et al
    Increased imported severe Plasmodium falciparum malaria involving hyperparasitaemia (>10%) in a UK hospital following relaxation of COVID-19 restrictions compared to the pre-pandemic period.
    J Travel Med. 2022 Oct 9. pii: 6754372. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2022
62. CHEMAITELLY H, Nagelkerke N, Ayoub HH, Coyle P, et al
    Duration of immune protection of SARS-CoV-2 natural infection against reinfection.
    J Travel Med. 2022 Sep 30. pii: 6731972. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. WANG S, Zhang F, Wang Z, Du Z, et al
    Reproduction numbers of SARS-CoV-2 Omicron subvariants.
    J Travel Med. 2022 Sep 30. pii: 6731971. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. CHEN LH, Connor BA
    Is standby therapy for Covid-19 a practical option for travellers?
    J Travel Med. 2022 Sep 24. pii: 6713538. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. SHAO Z, Ma L, Bai Y, Tan Q, et al
    Impact of mass rapid antigen testing for SARS-CoV-2 to mitigate Omicron outbreaks in China.
    J Travel Med. 2022 Sep 24. pii: 6713539. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. PEREZ-LOPEZ A, Al Mana H, Iqbal M, Suleiman M, et al
    Resurgence of influenza A infections in children after the relaxation of COVID-19-related social distancing measures and normalization of international travel in Qatar.
    J Travel Med. 2022 Sep 23. pii: 6712676. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. MARTINS-FILHO PR, Souza Araujo AA, Quintans-Junior LJ
    Global online public interest in monkeypox compared with COVID-19: Google trends in 2022.
    J Travel Med. 2022 Sep 20. pii: 6708352. doi: 10.1093.
    PubMed    
    
    
    August 2022
68. HINCAPIE R, Munoz D, Ortega N, Isfeld-Kiely HK, et al
    Effect of Flight Connectivity on Introduction and Evolution of COVID-19 in Canadian Cities.
    J Travel Med. 2022 Aug 30. pii: 6679266. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. YADAV SK, Akhter Y
    The reproductive numbers of SARS-CoV-2 vary depending on the compartmental model used during epidemiological modeling.
    J Travel Med. 2022 Aug 12. pii: 6663936. doi: 10.1093.
    PubMed    
    
    
    
70. KAMENSHCHIKOVA A, Hargreaves S, Chandler CIR
    Management of cross-border mobilities during the SARS-CoV-2 pandemic in Europe and implications for public health provision to migrants.
    J Travel Med. 2022 Aug 6. pii: 6657743. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2022
71. KUMAR NP, Banurekha VV, Kumar CPG, Nancy A, et al
    Covaxin induced antibody responses.
    J Travel Med. 2022 Jul 28. pii: 6651027. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. HAN C, Ryu S, Shin H, Kim D, et al
    Impact of national lockdown on the suspected SARS-CoV-2 epidemic in terms of the number of fever cases in North Korea.
    J Travel Med. 2022 Jul 28. pii: 6651005. doi: 10.1093.
    PubMed    
    
    
    
73. VINCETI M, Balboni E, Rothman KJ, Teggi S, et al
    Substantial impact of mobility restrictions on reducing COVID-19 incidence in Italy in 2020.
    J Travel Med. 2022 Jul 24. pii: 6649390. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. NORMAN FF, Trevino-Maruri B, Giardin JMR, Gullon-Pena B, et al
    Trends in Imported Malaria during the COVID-19 pandemic, Spain (+Redivi Collaborative Network).
    J Travel Med. 2022 Jul 24. pii: 6649393. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2022
75. HUITS R, Hamer DH
    Malaria in sub-Saharan Africa-a continuing risk for international travellers.
    J Travel Med. 2022 Jun 23. pii: 6614631. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. BAI Y, Du Z, Xu M, Sc M, et al
    International risk of SARS-CoV-2 omicron variant importations originating in South Africa.
    J Travel Med. 2022 Jun 15. pii: 6608762. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2022
77. RADER B, Whaley CM, Rogers WS, Brownstein PJS, et al
    Assessment of geographic access to monoclonal antibodies in the United States.
    J Travel Med. 2022;29.
    PubMed    
    
    
    
78. QASSIM SH, Chemaitelly H, Ayoub HH, AlMukdad S, et al
    Effects of BA.1/BA.2 subvariant, vaccination, and prior infection on infectiousness of SARS-CoV-2 omicron infections.
    J Travel Med. 2022 May 27. pii: 6594077. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. HOTEZ PJ
    COVID-19 Vaccines: The Imperfect Instruments of Vaccine Diplomacy.
    J Travel Med. 2022 May 24. pii: 6591167. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. PEREZ-LOPEZ A, Al Mana H, Iqbal M, Suleiman M, et al
    Variations in respiratory syncytial virus activity following the relaxation of COVID-19 restrictions in Qatar.
    J Travel Med. 2022 May 23. pii: 6590686. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. LIEU A, Mah J, Desgagnes N, Pillai D, et al
    The impact of the COVID-19 pandemic on malaria in returning travellers in Canada: a retrospective population-based cohort study.
    J Travel Med. 2022 May 14. pii: 6585752. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. AL-TAWFIQ JA, Kattan RF, Memish ZA
    Escalating the 2022 Hajj during the third year of the COVID-19 pandemic.
    J Travel Med. 2022 May 9. pii: 6582521. doi: 10.1093.
    PubMed    
    
    
    
83. NGEH S, Vogt F, Sikazwe CT, Levy A, et al
    Travel-associated SARS-CoV-2 transmission documented with whole genome sequencing following a long-haul international flight.
    J Travel Med. 2022 May 7. pii: 6582210. doi: 10.1093.
    PubMed     Abstract available
    
    
    
84. BESANCON L, Flahault A, Meyerowitz-Katz G
    Mobility during the pandemic: how did our movements shape the course of COVID-19?
    J Travel Med. 2022 May 3. pii: 6577267. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2022
85. SEKIZUKA T, Saito M, Itokawa K, Sasaki N, et al
    Recombination between SARS-CoV-2 omicron BA.1 and BA.2 variants identified in a traveller from Nepal at the airport quarantine Facility in Japan.
    J Travel Med. 2022 Apr 20. pii: 6571346. doi: 10.1093.
    PubMed    
    
    
    
86. DU Z, Liu C, Wang L, Bai Y, et al
    Shorter serial intervals and incubation periods in SARS-CoV-2 variants than the SARS-CoV-2 ancestral strain.
    J Travel Med. 2022 Apr 20. pii: 6571349. doi: 10.1093.
    PubMed    
    
    
    
87. GUO Z, Zhao S, Lee SS, Mok CKP, et al
    Superspreading potential of COVID-19 outbreak seeded by Omicron variants of SARS-CoV-2 in Hong Kong.
    J Travel Med. 2022 Apr 18. pii: 6569870. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. PASSOS-CASTILHO AM, Labbe AC, Barkati S, Luong ML, et al
    Outcomes of hospitalized COVID-19 in Canada: impact of ethnicity, migration status, and country of birth ethnicity, migration and COVID-19 in-hospital outcomes in Canada.
    J Travel Med. 2022 Apr 13. pii: 6567954. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2022
89. GUEST C, Dewhirst SY, Lindsay SW, Allen DJ, et al
    Using trained dogs and organic semi-conducting sensors to identify asymptomatic and mild SARS-CoV-2 infections: an observational study.
    J Travel Med. 2022 Mar 24. pii: 6553800. doi: 10.1093.
    PubMed     Abstract available
    
    
    
90. SAPKAL G, Deshpande GR, Tilekar B, Yadav P, et al
    Antibody responses to Sputnik Vaccination in naive and COVID 19-recovered vaccine recipients, India.
    J Travel Med. 2022 Mar 24. pii: 6552922. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. DESHPANDE GR, Yadav PD, Abraham P, Nyayanit DA, et al
    Booster dose of the inactivated COVID-19 vaccine BBV152 (Covaxin) enhances the neutralizing antibody response against alpha, Beta, Delta and omicron variants of concern.
    J Travel Med. 2022 Mar 24. pii: 6553803. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. LIU Y, Rocklov J
    The effective reproduction number for the omicron SARS-CoV-2 variant of concern is several times higher than Delta.
    J Travel Med. 2022 Mar 9. pii: 6545354. doi: 10.1093.
    PubMed     Abstract available
    
    
    
93. SAPKAL G, Srivastava RK, Dwivedi G, Sahay RR, et al
    Immune responses against different variants of SARS-CoV-2 including omicron following six months of administration of heterologous prime-boost COVID-19 vaccine.
    J Travel Med. 2022 Mar 4. pii: 6542352. doi: 10.1093.
    PubMed    
    
    
    
94. MOUSA M, Albreiki M, Alshehhi F, AlShamsi S, et al
    Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the United Arab Emirates.
    J Travel Med. 2022 Mar 4. pii: 6542351. doi: 10.1093.
    PubMed    
    
    
    
95. OKANO JT, Valdano E, Mitonga HK, Blower S, et al
    Predicting the transmission of SARS-CoV-2 in Africa: the case of Namibia.
    J Travel Med. 2022 Mar 3. pii: 6541667. doi: 10.1093.
    PubMed    
    
    
    
96. ACOSTA RW, Visser JT, Chen LH, Leggat PA, et al
    Adaptation of travel medicine practitioners to the COVID-19 pandemic: a cross-sectional survey of ISTM members.
    J Travel Med. 2022 Mar 3. pii: 6541666. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. ZHAO S, Guo Z, Chong MKC, He D, et al
    Superspreading potential of SARS-CoV-2 Delta variants under intensive disease control measures in China.
    J Travel Med. 2022 Mar 2. pii: 6541142. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2022
98. AU NH, Thomas-Bachli A, Forsyth J, Demarsh PA, et al
    Identifying importation points of the SARS-CoV-2 omicron variant into the United States and potential locations of early domestic spread and impact.
    J Travel Med. 2022 Feb 23. pii: 6534726. doi: 10.1093.
    PubMed     Abstract available
    
    
    
99. HE D, Sun C, Shang Z, Yang Y, et al
    Multiple small pneumatoceles as a complication of a SARS-CoV-2 infection in a child from Myanmar.
    J Travel Med. 2022 Feb 23. pii: 6534725. doi: 10.1093.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum